All Type of News
Use of standardized oriental medicines eyed
Oriental clinics and hospitals will be obliged to use oriental medicines listed in the compendium of natural preparations, the Ministry of Health and Welfare said recently.
According to the newly revised medical la...
Domestic pharmaceutical firms stingy on R&D
Korean pharmaceutical companies are spending little money on research and development (R&D) activities as they focus more on marketing and advertisement outlays, a lawmaker said recently citing government statisti...
Drug industry unlikely to achieve their sales forecast.
Most of local pharmaceutical companies seem hardly to achieve their sales target this year mainly because of the KFDA's delayed approval for the applications of new products stemming from the bio equivalency scandals ...
Choong-wae Pharm launches new diabetic agent Glufast tab.Choonwae-Pharm said it has recently launched a new product Glufast tablet (mitiglinide) for the treatment of type II diabetes.
Glufast is an insulin secretagogue with a rapid...
|
Allergan conducting Phase III program for Posurdex in Korea
Allergan, the U.S.-based global health care company, is currently conducting two Phase III clinical programs in 100 hospitals worldwide with Posurdex, the first biodegradable ocular implant, focusing on macular edema ...
Samjin appointed as one of 200 Best Asian industries.
Forbes Asia, a famous American economic journal, reported that 5 local small and medium sized drug companies including Hanmi, Samjin, Bukwang, Whanin and Yuyu were nominated as one of the 200 Best Under a Billion.
...
Korea do not accept extension of patent period by 5 years
The Ministry of Health and Welfare said The Korean government has not promised to accept the U.S. government's requests regarding an extension of the patent period by five years for their drugs to increase their price...
A foreign adviser: Local industry to seek overseas OTC markets
Mr. Nicholas Hall recently visited to Korea by an invitation of Zuellig Korea. He is an international OTC drug market expert and runs a consultation company named "Nicholas Hall & Co". During his visit to Korea, a pre...
Mandatory ingredient labeling system for cosmetics eyed
A regulation requiring cosmetic products sold in Korea to list all ingredients on the label is under review, according to the Korea Food and Drug Administration (KFDA).
To that end, a working-level team consisting ...
Daewoong Pharm seeks bigger market share of NaramigDaewoong Pharm plans to expand its share of Naramig tablets (naratriptan) as one of the leading items in the local anti-migraine drug market.
Naratriptan is a triptan drug de...
|
